Evidence map›Paper›PMID 19124504›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2009

Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.

Veronica Wendy Setiawan, Jennifer A Doherty, Xiao-Ou Shu, Mohammad R Akbari, Chu Chen, Immaculata De Vivo, Angela Demichele, Montserrat Garcia-Closas, Marc T Goodman, Christopher A Haiman and 18 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 3 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. A Review onGenes · 2022
    Review
  8. Article
  9. Serum Estradiol and 20 Site-Specific Cancers in Women: Mendelian Randomization Study.The Journal of clinical endocrinology and metabolism · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2017
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 15 institutions in 4 countries.

Veronica Wendy SetiawanDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Jennifer A Doherty
Xiao-Ou Shu
Mohammad R Akbari
Chu Chen
Immaculata De Vivo
Angela Demichele
Montserrat Garcia-Closas
Marc T Goodman
Christopher A Haiman
Susan E Hankinson
Brian E Henderson
Pamela L Horn-Ross
James V Lacey
Loic Le Marchand
Douglas A Levine
Xiaolin Liang
Jolanta Lissowska
Galina Lurie
Monica McGrath
Steven A Narod
Timothy R Rebbeck
Giske Ursin
Noel S Weiss
Yong-Bing Xiang
Hannah P Yang
Wei Zheng
Sara H Olson
University of Southern California · USFred Hutch Cancer Center · USNational Cancer Institute · USBrigham and Women's Hospital · USMemorial Sloan Kettering Cancer Center · USUniversity of Pennsylvania · USUniversity of Toronto · CAVanderbilt University Medical Center · USCancer Prevention Institute of California · USCancer Research Center · USHarvard University · USShanghai Cancer Institute · CNThe Maria Sklodowska-Curie National Research Institute of Oncology · PLUniversity of Hawaiʻi at Mānoa · USUniversity of Hawaii System · US

Funding

CALIFORNIA TEACHERS STUDYR01CA077398 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERNSTEIN, LESLIE · 1998 to 2014
$29.7M
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSR01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2001 to 2005
$23.2M
Multiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2M
VALIDATION OF A DIET HISTORY METHOD FOR EPIDEMIOLOGIC STUDIES OF CANCERP01CA033619 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 1985 to 2010
$18.5M
Hormones/Genes in Women's Health: From Bench to BedsideK12HD051959 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI GOLDSTEIN, JILL M, REXRODE, KATHRYN M · 2005 to 2023
$8.8M
MOLECULAR SUSCEPTIBILITY TO HORMONE INDUCED CANCERP01CA077596 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BERLIN, JESSE A · 1998 to 2002
$5.6M
COLLABORATIVE STUDY OF OVARIAN CANCER IN TWO RISK GROUPSR01CA058598 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GOODMAN, MARC T · 1993 to 2012
$4.6M
MULTIETHNIC/MINORITY COHORT STUDY OF DIET AND CANCERR01CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 1993 to 2002
$4.5M
Molecular Pathoepidemiology of Endometrial Cancer RiskR01CA082838 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI DE VIVO, IMMACULATA · 1999 to 2015
$4.3M
GENES AND THE ESTROGEN EFFECT ON ENDOMETRIAL CANCERR01CA091019 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI URSIN, GISKE · 2002 to 2006
$3.9M
Steroid Hormone Genes and Ovarian Cancer RiskR01CA112523 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSING, MARY ANNE · 2006 to 2010
$3.3M
ESTROGEN, DIET, GENETICS AND ENDOMETRIAL CANCERR01CA083918 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI OLSON, SARA H · 2001 to 2005
$2.5M
Intramural NIH HHSNCI NIH HHS CA077398NCI NIH HHS CA105212NCI NIH HHS CA112523NCI NIH HHS CA116543NCI NIH HHS CA33619NCI NIH HHS CA39779NCI NIH HHS CA54281NCI NIH HHS CA58598NCI NIH HHS CA63464NCI NIH HHS CA75977NCI NIH HHS CA77596NCI NIH HHS CA80636NCI NIH HHS CA82838NCI NIH HHS CA83918NCI NIH HHS CA91019NCI NIH HHS CA92002NCI NIH HHS CA92585NCI NIH HHS CN67001NCI NIH HHS K05 CA092002NCI NIH HHS K07 CA116543NCI NIH HHS N01 PC035137NCI NIH HHS N01-PC-35137NCI NIH HHS P01 CA033619NCI NIH HHS P01 CA077596NCI NIH HHS R01 CA054281NCI NIH HHS R01 CA058598NCI NIH HHS R01 CA063464NCI NIH HHS R01 CA077398NCI NIH HHS R01 CA082838NCI NIH HHS R01 CA083918NCI NIH HHS R01 CA091019NCI NIH HHS R01 CA092585NCI NIH HHS R01 CA105212NCI NIH HHS R01 CA112523NCI NIH HHS R03 CA080636NCI NIH HHS R37 CA054281NCI NIH HHS U01 CA063464NICHD NIH HHS K12 HD051959NICHD NIH HHS K12 HD051959-01NICHD NIH HHS N01 HD023166
6 · The paper itself

Abstract

Common variants in CYP19A1 (the A alleles of rs749292 and rs727479) have been associated with a 10% to 20% increase in circulating estrogen levels in postmenopausal women. We hypothesized that the presence of one or both A alleles in these single nucleotide polymorphisms (SNP) is associated with increased endometrial cancer risk. We tested this hypothesis in a large pooled analysis of 4,998 endometrial cancer cases and 8,285 controls from 10 studies in the Epidemiology of Endometrial Cancer Consortium. The majority of women (>66%) were whites, with smaller proportions of other races and ethnic groups (blacks, Asians, and Latinas) also included in this pooled analysis. Unconditional logistic regression was used to model the association between SNPs/haplotypes and endometrial cancer risk. Carrying the A allele of either of these SNPs was associated with an increased risk of endometrial cancer, with pooled odds ratios per allele of 1.14, 95% confidence interval of 1.09-1.21, and P = 7.1 x 10(-7) for rs749292, and odds ratio per allele of 1.08, 95% confidence interval of 1.02-1.14, and P = 0.009 for rs727479. For rs749292, these associations were generally stronger among women age >or=55 years. For both SNPs, risk increased with increasing body mass index, and for rs727479, this pattern seemed stronger among women age >or=55 years (P interaction = 0.007). The combination of A alleles in the two SNPs, either by direct count or by haplotype analysis, did not increase risk above that observed for the individual SNPs. Our study provides evidence that CYP19A1 genetic variation influences susceptibility to endometrial cancer, particularly among older and obese women.

Indexed as

Genetic VariationPolymorphism, Single NucleotideAgedAge FactorsAllelesAromataseCase-Control StudiesEndometrial NeoplasmsEstrogensFemaleGene FrequencyGenotypeHumansLogistic ModelsMiddle AgedObesityAromataseEstrogens

Identifiers

PMID19124504
PMCPMC2668570
OpenAlexW2164615447

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.